Dermatology · Yardley, PA
NPI
1801835426
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
903 Floral Vale Blvd
Yardley, PA, 19067
Phone (215) 579-6155
Groups this clinician bills Medicare through
Medicare paid, 2024
$239K
4,370 services
Medicare patients, 2024
794
Average age 74
Drug cost, 2024
$376K
1,291 prescriptions
Company payments, 2025
$3,765
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard G Fried was code 17003 (destruction skin lesion), 1,344 times for 259 patients. In total Richard G Fried billed 4,370 services in 46 codes, and Medicare paid $239K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,344 | 259 | $5.32 | $7,144 |
| 99213 Office E&M - Established | Office | 857 | 605 | $64.50 | $55K |
| 17110 Destruction Skin Lesion | Office | 495 | 409 | $81.15 | $40K |
| 17000 Destruction Skin Lesion | Office | 447 | 337 | $37.72 | $17K |
| 96910 Skin | Office | 313 | 15 | $99.27 | $31K |
| 99214 Office E&M - Established | Office | 175 | 151 | $98.52 | $17K |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 83 | 59 | $303.69 | $25K |
| 99212 Office E&M - Established | Office | 82 | 65 | $41.40 | $3,395 |
| 96567 Skin | Office | 80 | 59 | $105.26 | $8,421 |
| 11102 Skin Biopsy | Office | 70 | 69 | $54.66 | $3,826 |
| 11104 Skin Biopsy | Office | 33 | 33 | $101.31 | $3,343 |
| 11302 Removal or Shaving of Skin Growth | Office | 28 | 27 | $104.97 | $2,939 |
| 11301 Removal or Shaving of Skin Growth | Office | 27 | 26 | $91.06 | $2,459 |
| 99203 Office E&M - New | Office | 26 | 26 | $79.92 | $2,078 |
| 10060 Skin | Office | 24 | 24 | $98.65 | $2,368 |
By year: 2022 $246K for 4,088 services; 2023 $241K for 4,456 services; 2024 $239K for 4,370 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard G Fried prescribed most often to Medicare patients was Doxycycline Hyclate, with 147 prescriptions and refills. In total Richard G Fried wrote 1,291 Medicare prescriptions that cost $376K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 147 | 237 | 46 | $3,909 |
| Minoxidil Generic | 144 | 266 | 34 | $1,266 |
| Fluorouracil Generic | 100 | 106 | 91 | $5,437 |
| Pimozide Generic | 83 | 101 | 23 | $7,737 |
| Ivermectin Generic | 66 | 93 | 28 | $9,039 |
| Triamcinolone Acetonide Generic | 62 | 66 | 39 | $950 |
| Hydrocortisone Generic | 54 | 57 | 37 | $397 |
| Mometasone Furoate Generic | 48 | 50 | 34 | $662 |
| Ciclopirox Ciclopirox Olamine | 39 | 43 | 25 | $457 |
| Propranolol Hcl Generic | 33 | 69 | Under 11 | $626 |
| Tacrolimus Generic | 26 | 26 | 14 | $2,198 |
| Mupirocin Generic | 25 | 25 | 18 | $194 |
| Fluconazole Generic | 25 | 25 | 18 | $92.26 |
| Valacyclovir Valacyclovir Hcl | 25 | 30 | 11 | $257 |
| Clobetasol Propionate Generic | 22 | 22 | 16 | $475 |
Brand drugs: 123 claims; generic drugs: 1,168 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard G Fried $3,765 ($3,765 in general payments such as food, travel and fees) from 16 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $3,000.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 1 | $3,000 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $144 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $136 |
| UCB, Inc. UCB.BR | 1 | $123 |
| Genzyme Corporation SNY | 2 | $50.56 |
| Lilly USA, LLC LLY | 2 | $45.47 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $43.83 |
| Pfizer Inc. PFE | 2 | $41.72 |
| LEO Pharma Inc. | 2 | $40.87 |
| Incyte Corporation INCY | 1 | $27.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.